These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26629)

  • 21. Plasma prekallikrein activity in patients with total hip arthroplasty.
    Hoffmann JJ; Kortmann JH
    Thromb Haemost; 1987 Dec; 58(4):1040-2. PubMed ID: 3445224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Determination of prekallikrein in human plasma by kaolin adsorption method (author's transl)].
    Niwano A; Ikeda K; Yamada T; Naka H; Kiyose H; Hiraku S; Tamura S; Kira H; Hirata F
    Rinsho Byori; 1982 Mar; 30(3):315-9. PubMed ID: 6921272
    [No Abstract]   [Full Text] [Related]  

  • 23. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ; Dooijewaard G; Turion PN
    Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pro-urokinase and prekallikrein are both associated with platelets. Implications for the intrinsic pathway of fibrinolysis and for therapeutic thrombolysis.
    Gurewich V; Johnstone M; Loza JP; Pannell R
    FEBS Lett; 1993 Mar; 318(3):317-21. PubMed ID: 8440390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An optimized assay for prekallikrein activator activity in human plasma products.
    Tölö H; Suomela H
    Thromb Res; 1982 Jul; 27(1):35-44. PubMed ID: 6981866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analyses of factor XII, prekallikrein and kallikrein inhibitory capacity in patients with laboratory signs of DIC.
    Egberg N; Hellgren M
    Scand J Clin Lab Invest Suppl; 1985; 178():25-9. PubMed ID: 3867118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contact activation of human plasma prorenin in vitro.
    Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
    J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The assay of glandular kallikrein and prekallikrein in human mixed saliva.
    Jenzano JW; Coffey JC; Heizer WD; Lundblad RL; Scicli AG
    Arch Oral Biol; 1988; 33(9):641-4. PubMed ID: 3245788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Method of simultaneous determination of kallikrein, plasmin and thrombin precursors and inhibitors in human blood plasma].
    Gomazkov OA; Komissarova NV
    Biull Eksp Biol Med; 1976 May; 81(5):632-4. PubMed ID: 132976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema.
    Joseph K; Tholanikunnel BG; Kaplan AP
    J Allergy Clin Immunol; 2017 Jul; 140(1):170-176. PubMed ID: 27826093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Physiological and pathological significance of plasma prekallikrein in obstetrics].
    Soga K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1763-72. PubMed ID: 6924684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of the prekallikrein-kallikrein system of the blood plasma in children with viral hepatitis].
    Veremeenko GI; Moshchich PS; Vasilenko GI; Meged' NF
    Pediatr Akus Ginekol; 1977; (1):28-30. PubMed ID: 882294
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on plasma prekallikrein assay method with chromogenic substrates (S-2302)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1983 Feb; 31(2):219-22. PubMed ID: 6190027
    [No Abstract]   [Full Text] [Related]  

  • 34. Acetylcysteine in rats: inhibition of activation of prekallikrein and factor XII--protection against dextran-induced blood pressure fall.
    Hoem NO; Briseid G
    Pharmacol Toxicol; 1987 Feb; 60(2):140-4. PubMed ID: 2437551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Falls in plasma levels of prekallikrein, high molecular weight kininogen, and kallikrein inhibitors during lethal endotoxin shock in dogs.
    Gallimore MJ; Aasen AO; Lyngaas KH; Larsbraaten M; Amundsen E
    Thromb Res; 1978 Feb; 12(2):307-18. PubMed ID: 565085
    [No Abstract]   [Full Text] [Related]  

  • 36. Assay of prekallikrein in human plasma: comparison of amidolytic, esterolytic, coagulation, and immunochemical assays.
    Fisher CA; Schmaier AH; Addonizio VP; Colman RW
    Blood; 1982 May; 59(5):963-70. PubMed ID: 6803857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dextran-induced lowering of prekallikrein proactivator and prekallikrein in rat plasma.
    Briseid G; Briseid K; Toverud EL; Kristoffersen J
    Acta Pharmacol Toxicol (Copenh); 1978 Feb; 42(2):93-102. PubMed ID: 580160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amidolytic prekallikrein (PK) assay: unsuitability of Cephotest as an activator.
    Lämmle B; Lohri A; Tran TH; Czendlik C
    Thromb Haemost; 1984 Apr; 51(2):294. PubMed ID: 6564798
    [No Abstract]   [Full Text] [Related]  

  • 39. Septic shock in the rat: activation of plasma proteolytic systems and effects of a kallikrein inhibitor/bradykinin antagonist (S-2441).
    Högström H; Claeson G; Larsson-Backström C; Lundberg D; Wenngren E; Haglund U
    Acta Chir Scand; 1987 Mar; 153(3):161-4. PubMed ID: 3300117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays.
    Saito H
    Adv Exp Med Biol; 1979; 120A():165-72. PubMed ID: 573961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.